← Back to headlines
Legend Biotech Stock Jumps 42% on Positive Cancer Therapy Results
Legend Biotech (LEGN) shares soared by 42% following the announcement of promising results from its cancer therapy trials, exciting investors in the biotech sector.
3 Jun, 00:14 — 3 Jun, 00:14
Sources
Showing 1 of 1 sources
